(2-Acetyl-4-methylpentyl)trimethylammonium Iodide (CAS No: 1069-62-1) is a key pharmaceutical intermediate used in the synthesis of APIs Deutetrabenazine, Tetrabenazine and Valbenazine. This compound serves as an essential raw material in API development and synthesis. Explore detailed chemical properties, molecular data, structure information, and verified global suppliers, manufacturers, and distributors of this API intermediate on apicule.
Alternate Names: (2-Acetyl-4-methyl-pentyl)-trimethyl-ammonium, 2-acetyl-N,N,N,4-tetramethylpentan-1-aminiumiodide
CAS No: 1069-62-1
PubChem CID: 86641883
Mol Formula: C11H24INO
Mol Weight: 313.22 g/mol
Used in APIs: Deutetrabenazine, Tetrabenazine and Valbenazine
IUPAC Name: (2-acetyl-4-methylpentyl)-trimethylazanium iodide
API Intermediate Description: (2-Acetyl-4-methylpentyl)trimethylammonium Iodide (CAS 1069-62-1) is primarily known as a known impurity or intermediate in the synthesis of Tetrabenazine (TBZ), a drug used to treat hyperkinetic movement disorders like chorea in Huntington's Disease, rather than a direct therapeutic agent for TBZ. It's a related compound, often used as a reference standard to monitor Tetrabenazine purity, and its chemical structure is related to the isoquinoline backbone of Tetrabenazine.